StockIQ.techBrightSpring Health Services, Inc. (BTSG) Stock Analysis
Free AI-powered analysis and research for BrightSpring Health Services, Inc. stock
Sector: Healthcare
BTSG snapshot
Data as of 3 Nov 2026 close. Updated daily.
BrightSpring Health Services, Inc. scores 75/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 87% of its 52-week range, up 103.0% over the past year. Latest reported figures show a profit margin of 2.5%, return on equity of 13.0% and revenue growth of +23.0%.
What is driving the score
- Strong Uptrend: +12
- MACD Bullish: +8
- High P/E (53.6): -10
- Strong Revenue Growth (23.0%): +8
- Weak Profit Margin (2.5%): -8
- High P/B (6.09): -5
- Strong Long-term Uptrend: +8
- Very Strong Rise (+103.0% over 1 year): +12
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full BTSG report
BrightSpring Health Services, Inc. (BTSG) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze BTSG Now →📰 Latest Update
BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growth
Mon, November 2, 2026 at 2:00 PM UTC 3 min read
BrightSpring Health Services, Inc. (BTSG) reported a strong Q3, with adjusted EPS of $0.54 surpassing estimates and revenues of $4.21 billion exceeding expectations. The company raised its 2026 revenue guidance to $15.9-$16.125 billion, driven by specialty pharmacy demand and home health expansion, while reaffirming expectations for 15-20% organic adjusted EBITDA growth in 2027. Despite a decline in Home and Community Pharmacy revenues, overall performance reflects broad-based execution across its pharmacy and provider operations.